United States · FDA National Drug Code directory

Ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-749_6b5fe0aa-c74f-42f3-a84a-1cb16009aa80
Product NDC
71205-749
Form
TABLET, COATED
Composition / generic term
Ciprofloxacin
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20200812
Source listing expiry
20261231

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 TABLET, COATED in 1 BOTTLE (71205-749-05) · 71205-749-05
  • 6 TABLET, COATED in 1 BOTTLE (71205-749-06) · 71205-749-06
  • 10 TABLET, COATED in 1 BOTTLE (71205-749-10) · 71205-749-10
  • 14 TABLET, COATED in 1 BOTTLE (71205-749-14) · 71205-749-14
  • 20 TABLET, COATED in 1 BOTTLE (71205-749-20) · 71205-749-20
  • 28 TABLET, COATED in 1 BOTTLE (71205-749-28) · 71205-749-28
  • 30 TABLET, COATED in 1 BOTTLE (71205-749-30) · 71205-749-30
  • 60 TABLET, COATED in 1 BOTTLE (71205-749-60) · 71205-749-60
  • 90 TABLET, COATED in 1 BOTTLE (71205-749-90) · 71205-749-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →